The involvement of human ribonucleases H1 and H2 in the variation of response of cells to antisense phosphorothioate oligonucleotides

European Journal of Biochemistry

Volumn 269, Issue 2, 2002, Pages 583-592

  Ten Asbroek, Anneloor L M A ^a   Van Groenigen, Marjon ^a   Nooij, Marleen ^a   Baas, Frank ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Antisense; Human; Phosphorothioate; Ribonuclease; RNase H

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; LIPOSOME; MESSENGER RNA; OLIGODEOXYNUCLEOTIDE PHOSPHOROTHIOATE; PROTEIN DERIVATIVE; RAS PROTEIN; REPLICATION PROTEIN A; RIBONUCLEASE; RIBONUCLEASE H; RIBONUCLEASE H2; RNA POLYMERASE II; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CELL ACTIVITY; CELL LINE; CELL TYPE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ELECTROPORATION; ENZYMATIC ASSAY; ENZYME ACTIVITY; ENZYME ANALYSIS; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN TARGETING; SITE DIRECTED MUTAGENESIS;

CELL LINE; HUMANS; OLIGONUCLEOTIDES, ANTISENSE; ORGANOPHOSPHORUS COMPOUNDS; PLASMIDS; RIBONUCLEASE H, CALF THYMUS; RNA, MESSENGER; THIONUCLEOTIDES; TRANSFECTION;

EID: 0036164420     PISSN: 00142956     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.0014-2956.2001.02686.x     Document Type: Article

References (46)

1. Enzyme from calf thymus degrading the RNA moiety of DNA-RNA hybrids: Effect on DNA-dependent RNA polymerase
2. Ribonuclease H, an enzyme degrading the RNA moiety of DNA-RNA hybrids
3. Ribonucleases H of retroviral and cellular origin
4. Crystal structure of the ribonuclease H domain of HIV-1 reverse tramscriptase
5. Three-dimensional structure of ribonuclease H from E. coli
6. Identification of the amino acid residues involved in an active site of Escherichia coli ribonuclease H by site-directed mutagenesis
7. Structure of ribonuclease H phased at 2 Å resolution by MAD analysis of the selenomethionyl protein
8. Purification, subunit structure, and serological analysis of calf thymus ribonuclease H I
9. DNA primase stimulatory factor from mouse FM3A cells has an RNase H activity. Purification of the factor and analysis of the stimulation
10. Renaturase and ribonuclease H: A novel mechanism that influences transcript displacement by RNA polymerase II in vitro
11. Purification and characterization of human ribonuclease HII
12. Ribonuclease H from K562 human erythroleukemia cells. Purification, characterization, and substrate specificity
13. Distinct ribonuclease H activities in calf thymus
14. Isolation and characterization of two types of ribonucleases H in Krebs II ascites cells
15. DNA sequence of the gene coding for Escherichia coli ribonuclease H
16. Isolation and characterization of a second RNase H (RNase HII) of Escherichia coli K-12 encoded by the rnhB gene
17. Cloning, expression, and mapping of ribonucleases H of human and mouse related to bacterial RNase HI
18. Cloning, subcellular localization and functional expression of human RNase HII
19. Cloning of the cDNA encoding the large subunit of human RNase HI, a homologue of the prokaryotic RNase HII
20. Molecular cloning and expression of cDNA for human RNase H
21. Properties of cloned and expressed human RNase H1
22. 2+-dependent HIII from Bacillus subtilis: Classification of RNases H into three families
23. Function of RNase H in DNA replication revealed by RNase H defective mutants of Escherichia coli
24. Enzymatic completion of mammalian lagging-strand DNA replication
25. Mechanism of DNA chain growth. XV. RNA-linked nascent DNA pieces in Escherichia coli strains assayed with spleen exonuclease
26. Enzymes and reactions at the eukaryotic DNA replication fork
27. Molecular mechanisms of action of antisense drugs
28. Antisense oligonucleotides: Promise and reality
29. Polymorphisms in the large subunit of human RNA polymerase II as target for allele-specific inhibition
30. Selective killing of cancer cells based on loss of heterozygosity and normal variation in the human genome: A new paradigm for anticancer drug therapy
31. Selective inhibition of mutant Ha-ras mRNA expression by antisense oligonucleotides
32. High-efficiency gene transfection by in situ electroporation of cultured cells
33. Tritium labeling of antisense oligonucleotides by exchange with tritiated water
34. The vasopressin mRNA poly (A) tract is unusually long and increases during stimulation of vasopressin gene expression in vivo
35. Rapid determination and quantitation of the accessibility to native RNAs by antisense oligodeoxynucleotides in murine cell extracts
36. Eukaryotic ribonucleases HI and HII generate characteristic hydrolytic patterns on DNA-RNA hybrids: Further evidence that mitochondrial RNase H is an RNase HII
37. Cationic lipids enhance cellular uptake and activity of phosphorothioate antisense oligonucleotides
38. Phosphorothioate antisense oligonucleotides induce the formation of nuclear bodies
39. Rapid nuclear accumulation of injected oligodeoxyribonucleotides
40. Intracellular distribution of microinjected antisense oligonucleotides
41. Patterns of intracellular compartmentalization, trafficking and acidification of 5′-fluorescein labeled phosphodiester and phosphorothioate oligodeoxynucleotides in HL60 cells
42. Nucleocytoplasmic shuttling: A novel in vivo property of antisense phosphorothioate oligodeoxynucleotides
43. The absence of ribonuclease H1 or H2 alters the sensitivity of Saccharomyces cerevisiae to hydroxyurea, caffeine and ethyl methanesulphonate: Implications for roles of RNases H in DNA replication and repair
44. Modulation of gene expression in the central nervous system as a tool in behavioural pharmacology
45. Behavioural and neuroendocrine effects of antisense targeting in the rat
46. Electrophysiological and behavioural effects of dopamine receptor knockdown in the brain